Groupe la Francaise’s BioNTech BNTX Stock Holding History

Groupe la Francaise’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$391K	Hold	4,200	–	–	﹤0.01%	357
2026 Q1	$360K	Hold	4,200	–	–	﹤0.01%	348
2025 Q4	$400K	Sell	4,200 -485	-10%	-$48.9K	0.01%	323
2025 Q3	$462K	Buy	4,685 +485	+12%	+$51.9K	0.01%	352
2025 Q2	$445K	Hold	4,200	–	–	0.01%	321
2025 Q1	$418K	Hold	4,200	–	–	0.01%	317
2024 Q4	$478K	Buy	+4,200	New	+$479K	0.01%	240

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Groupe la Francaise's BNTX Position: Q2 2026 in Review

Groupe la Francaise held its BioNTech (BNTX) position steady in Q2 2026 at 4,200 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #357.

Groupe la Francaise first reported a position in BNTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $478K in Q4 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Groupe la Francaise held 4,200 shares of BioNTech worth $391K as of Q2 2026.
Groupe la Francaise left its BioNTech share count unchanged in Q2 2026.
BioNTech made up ﹤0.01% of Groupe la Francaise's portfolio in Q2 2026, its #357 holding.
Groupe la Francaise first reported a position in BioNTech in Q4 2024 and has held it in 7 quarters since.
Groupe la Francaise's BioNTech position peaked at $478K in Q4 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.